星状神经节阻滞联合鲁南欣康治疗耐药性心绞痛的临床研究  

A clinical study of the therapeutic effect of stellate ganglion block(SGB) combined with Lsosorbide Mononitrate Tablets(LMT) on the patients with drug-resistant Angina

作　　者：刘连忠[1] 黄美玲[1] 郭凯[1] 

机构地区：[1]山东省莱芜市人民医院麻醉科,山东莱芜271100

出　　处：《海南医学》2006年第4期39-40,共2页Hainan Medical Journal

摘　　要：目的观察星状神经节阻滞(SGB)联合鲁南欣康治疗耐药性心绞痛的有效性。方法65例耐药性心绞痛病人随机分为Ⅰ组(SGB联合鲁南欣康药物治疗)35例、Ⅱ组(单纯鲁南欣康药物治疗)。观察并记录治疗前后患者疼痛情况和2年内心血管相关事件发生情况。结果Ⅰ组有效率为100%,Ⅱ组有效率为67%,两组相比有显著性差异(P<0.05);治疗后2年内发生心脑血管缺血性相关事件Ⅰ组远低于Ⅱ组(P<0.05);再住院的病例Ⅱ组远高于Ⅰ组,具有显著性差异(P<0.01)。结论SGB联合鲁南欣康药物治疗耐药性心绞痛优于单纯鲁南欣康药物治疗。Objective To observe the therapeutic Lsosorbide Mononitrate Tablets （LMT） on the patients drug-resistant Angina were randomly assigned to group effect of stellate ganglion block （SGB） combined with with drug-resistant Angina. Methods 65 patients with Ⅰ （SGB combined with LMT, n=35） and group Ⅱ （LMT, po,bid, only, n=30）.Evaluate and record before and after the treatment the patients＇ condition and cardlc vascular accident related happened in two years. Results The effeeients in group Ⅰ and Ⅱ were 100% and 67%. There was significant difference between two groups （P〈0.05）; Patients with eardie-cerebro vascular inchaemic accident happened in two years after treatment were obviously lower than that in group Ⅱ （P〈0.05）; rehospitalized patients in group Ⅱ were evidently higher than that in group Ⅰ （P〈0.01）. Conclusions Using SGB combined with LMT to cure drug-resistant angina could be better than LMT only.

关 键 词：星状神经节阻滞 耐药性心绞痛 联合药物 

分 类 号：R541.4[医药卫生—心血管疾病]